ZB
ACOR

Zions Bancorporation’s Acorda Therapeutics ACOR Stock Holding History

Zions Bancorporation’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-26
Closed -$73K – 1010
2017
Q3 		$73K Buy
+26
New +$68.5K 0.01% 498
2016
Q2 		– Hold
0
– – – 955
2016
Q1 		– Hold
0
– – – 901
2015
Q4 		– Hold
0
– – – 819
2015
Q3 		– Hold
0
– – – 829
2015
Q2 		– Hold
0
– -$1K – 780
2015
Q1 		– Hold
0
– – – 897

Other funds holding ACOR

SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HEC
Hudson Executive Capital New York $151M AUM 60.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Zions Bancorporation's ACOR Position: Q4 2017 in Review

Zions Bancorporation sold out of Acorda Therapeutics (ACOR) in Q4 2017, closing a stake of 26 shares — an estimated $73K sold.

Zions Bancorporation first reported a position in ACOR in Q3 2017 and held it in 1 quarter. The position peaked at $73K in Q3 2017. 150 funds tracked by Wall St. Rank hold ACOR as of Q4 2017.

  • Zions Bancorporation reported no remaining Acorda Therapeutics position as of Q4 2017 after selling out during the quarter.
  • Zions Bancorporation sold 26 Acorda Therapeutics shares in Q4 2017, an estimated $73K.
  • Zions Bancorporation first reported a position in Acorda Therapeutics in Q3 2017 and held it in 1 quarter.
  • Zions Bancorporation's Acorda Therapeutics position peaked at $73K in Q3 2017.
  • 150 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q4 2017.

Based on Zions Bancorporation's 13F filing for Q4 2017, filed 14 Feb 2018.